Capital World Investors
HAE icon

Capital World Investors’s Haemonetics HAE Stock Holding History

Capital World Investors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-313,000
Closed -$20.9M – 618
2021
Q2 		$20.9M Sell
313,000
-974,600
-76% -$69M ﹤0.01% 528
2021
Q1 		$143M Buy
1,287,600
+105,000
+9% +$13M 0.03% 328
2020
Q4 		$140M Buy
1,182,600
+346,700
+41% +$37.3M 0.03% 314
2020
Q3 		$72.9M Buy
835,900
+215,800
+35% +$18.9M 0.02% 359
2020
Q2 		$55.5M Buy
620,100
+337,778
+120% +$34.1M 0.01% 356
2020
Q1 		$28.1M Buy
+282,322
New +$30.6M 0.01% 369
2014
Q1 		– Sell
-2,055,000
Closed -$86.6M – 509
2013
Q4 		$86.6M Buy
2,055,000
+671,726
+49% +$27.6M 0.02% 311
2013
Q3 		$55.2M Buy
+1,383,274
New +$58M 0.02% 338

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
LCP
LGT Capital Partners Pfaeffikon, Switzerland $1.88B AUM 20.37% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors's HAE Position: Q3 2021 in Review

Capital World Investors sold out of Haemonetics (HAE) in Q3 2021, closing a stake of 313,000 shares — an estimated $20.9M sold.

Capital World Investors first reported a position in HAE in Q3 2013 and held it in 8 quarters. The position peaked at $143M in Q1 2021. 245 funds tracked by Wall St. Rank hold HAE as of Q3 2021.

  • Capital World Investors reported no remaining Haemonetics position as of Q3 2021 after selling out during the quarter.
  • Capital World Investors sold 313,000 Haemonetics shares in Q3 2021, an estimated $20.9M.
  • Capital World Investors first reported a position in Haemonetics in Q3 2013 and held it in 8 quarters.
  • Capital World Investors's Haemonetics position peaked at $143M in Q1 2021.
  • 245 funds tracked by Wall St. Rank held Haemonetics as of Q3 2021.

Based on Capital World Investors's 13F filing for Q3 2021, filed 15 Nov 2021.